Chinese leader Xi Jinping assures President Rodrigo Duterte that the Philippines would be prioritized once China develops a vaccine against the coronavirus disease.
Malacañang revealed in a statement on Friday that this was among the issues discussed by the two leaders during their"open and focused" telephone conversation Thursday night.
On the other hand, Duterte stressed the need to cooperate with research trials aimed at developing a vaccine. The Philippines is, Presidential Spokesperson Harry Roque earlier said. The vaccine being developed by the Chinese Academy of Sciences, Sinopharm and the Wuhan Institute of Virology has entered the second phase of clinical trials, with 96 people being given the experimental vaccine, according to Chinese state broadcaster CGTN.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Duterte, Xi in telephone conversation after anniversary of PH-China relations
Read more »
Xi to Duterte: PH will be 'priority' recipient of China coronavirus vaccineChinese President Xi Jinping assured President Rodrigo Duterte of China's assistance with the coronavirus pandemic during their 38-minute call
Read more »
BREAKING: Duterte, Xi discuss pandemic response over phone — Chinese EmbassyICYMI: President Rodrigo Duterte and Chinese president Xi Jingping had a phone conversation on Thursday night, on the eve of the Philippine Independence Day celebrations, the Chinese Embassy in the country said. ArawNgKalayaan
Read more »
China to continue helping PH in its COVID-19 response — XiChinese President Xi Jinping has committed to President Duterte that China will continue to give its full support to the Philippines in responding to the COVID-19 pandemic.
Read more »
China to continue helping PH in its COVID-19 response — XiChinese President Xi Jinping has committed to President Duterte that China will continue to give its full support to the Philippines in responding to the COVID-19 pandemic.
Read more »